Clinical Trials for HER2-low Hormone Receptor Positive Breast Cancer

Find clinical trials for her2-low hormone receptor positive breast cancer. Discover research opportunities and treatment options in your area.

1 Active Trial Found

Showing 1 trial on this page

Page 1 of 1

A Phase II Study of HLX22 in Combination With Trastuzumab Deruxtecan in HER2-low, Hormone Receptor Positive Locally Advanced or Metastatic Breast Cancer Patients

NCT ID: NCT06832202

This clinical trial is studying a new treatment combination, HLX22 and Trastuzumab Deruxtecan (T-DXd), for patients with a specific type of breast cancer known as HER2-low, hormone receptor positiv...

Recruiting

Phase: PHASE2 Type: interventional Locations: Shanghai, Shanghai, China

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions